Published by Bupa's Health Information Team, June 2010.
This factsheet is for people who would like information about the main ways of staging and grading cancer.
Cancer develops when the cells of the body change and grow in an uncontrolled way. Doctors and surgeons stage and grade cancer to describe the size of the tumour and how far and fast it's growing. It's important because it can help determine what the best course of treatment is.
A Flash plug-in is required to view this animation
A cancerous (malignant) tumour is a lump of cells in your body that grows in an abnormal and uncontrolled way. Cancerous tumours can grow in one of your organs and spread to other parts of your body through your bloodstream or lymphatic system (part of your immune system). Cancers that spread (metastasise) in this way may form secondary tumours. Non-cancerous tumours that don't invade other tissues or spread to other parts of the body are known as benign.
If your doctor or surgeon suspects you have cancer, you will need to have tests to confirm a diagnosis. The tests will be specific for the type of cancer you may have. At this point, your doctor or surgeon will try to find out the size of your tumour, how far it has grown and the speed at which it may grow. This is called staging and grading and is used to describe solid, cancerous tumours.
Staging is important because it helps your specialist decide what the best treatment is for you, as well as determining the likely course of your cancer.
Staging is used by doctors and surgeons to describe the size of your tumour and how far it may have spread within your body.
The most commonly used method to describe cancers worldwide is called the TNM staging system.
Your doctor or surgeon will use the TNM staging system to describe your cancer if you have a solid tumour in your breast, head, neck or lungs, for example. A different staging system may be used for specific types of cancers.
The TNM system describes the size of your original (primary) tumour (T), whether any cancer cells have spread from your primary tumour and have reached nearby lymph nodes (N), and whether the cancer cells have spread further around your body (M). Each stage has numbers that are used to categorise your cancer more specifically.
T in TNM staging
The T in the TNM system stands for tumour. This part of the staging system generally describes the size or growth of your tumour.
N in TNM staging
The N in the TNM system stands for nodes (or lymph nodes). Your lymph nodes are small, bean-shaped organs that are part of your lymphatic system. This system contains fluid called lymph, which contains cells that fight infection.
Your doctor or surgeon will rate your cancer according to whether or not it has spread to any nearby lymph nodes.
If your cancer has spread to your lymph nodes it may mean that it has spread to other areas of your body too. Your doctor or surgeon can't always tell if this has happened, but in this situation he or she will probably suggest you have adjuvant (preventative) treatment. This means you may have chemotherapy, radiation therapy, or hormone therapy alongside you primary treatment to try and kill any cancer cells that may have broken away from your primary tumour.
M in TNM staging
The M in the TNM staging system stands for metastases. If your cancer has metastasised, this means it has spread to other parts of your body. Your doctor or surgeon will rate your cancer according to whether it has spread or not.
If you need more information about the stage of your cancer or what it means, ask your doctor or surgeon.
Some cancers, including lymphomas and liver cancer, aren't described using the TNM system. If you have a tumour that isn't classified by TNM, your doctor or surgeon may describe it with a numbered stage - ranging from 1 to 4.
The higher the number, the more your cancer is likely to have spread in your body. For example, Stage 1 (or early stage) refers to a small tumour that hasn't spread to your lymph nodes and Stage 4 (or advanced stage) refers to tumours that have spread to other major organs in your body. Your doctor or surgeon may also use a letter with a stage number to define your cancer further - for example, stage 2a or 2b - to refer to the tissues that the cancer has spread into, but this will depend on the particular type of cancer you have.
If you have bowel cancer, your doctor or surgeon may describe it using the Dukes lettered (A-D) system. However, the TNM system is gradually replacing Dukes letters.
Grading is used to describe what your tumour looks like under a microscope to get an idea of how it may progress.
If your doctor or surgeon suspects you have cancer, he or she will take a sample of cells from your tumour (a biopsy) to send to a laboratory for testing. The cancerous cells will be looked at under a microscope to try and find out the speed at which your tumour may grow and how aggressive it is. There are three grades used to rate cancer.
If you are unsure about how your cancer may be graded or need more information, ask your doctor or surgeon.
For answers to frequently asked questions on this topic, see Common questions.
For sources and links to further information, see Resources.
Related topics
Related tools
Free online health risk assessments and calculators.
Related health risk assessments
Bupa By You.
Affordable new health insurance.
Adaptable cover from 98p a day^
Get a quote
More information
Bupa can offer NHS and private patients professional cancer care and support at home including IV and oral chemotherapy via our Chemotherapy at Home Service.
This information was published by Bupa's Health Information Team and is based on reputable sources of medical evidence. It has been reviewed by appropriate medical or clinical professionals. Photos are only for illustrative purposes and do not reflect every presentation of a condition. The content is intended only for general information and does not replace the need for personal advice from a qualified health professional. For more details on how we produce our content and its sources, visit the About our Health Information page.
Publication date: June 2010